Atara Biotherapeutics Company

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Technology: Atrificial Vectors and Immune Cells, CAR-T therapy
Industry: PharmTech, Public
Headquarters: South San Francisco, California, United States
Founded Date: 2012-01-01
Employees Number: 251-500
Funding Status: IPO
Investors Number: 8
Total Funding: 59316156
Estimated Revenue: $10M to $50M
Last Funding Date: 2017-01-01
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership